Clinical Trial Update: Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for early empiric anti-tuberculosis therapy in sepsis patients in Sub-Saharan Africa is reported as status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Sepsis
• Tuberculosis

Snippet

Sponsor: University of Virginia | Conditions: Tuberculosis, HIV I Infection | Phase 3 | Status: UNKNOWN